Loading...
Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Japan
Direct oral anticoagulants (DOACs) were developed to compensate for the demerits of warfarin. In Japan, three factor Xa inhibitors are used for the treatment of venous thromboembolism (VTE): edoxaban, rivaroxaban, and apixaban. Despite problems, such as the inability to monitor their effect and the...
Saved in:
| Published in: | J Atheroscler Thromb |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Japan Atherosclerosis Society
2017
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5453680/ https://ncbi.nlm.nih.gov/pubmed/28392512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.RV17005 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|